Protective activity of ketoprofen lysine salt against the pulmonary effects induced by bradykinin in guinea-pigs

Inflammation Research

Volumn 45, Issue 5, 1996, Pages 259-264

  Daffonchio, L ^b   Rossoni, G ^a   Clavenna, G ^b   Omini, C ^b   Berti, F ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b Research and Development Department   (Italy)

Author keywords

Airway inflammation; Bradykinin; Bronchoconstriction; Ketoprofen lysine salt; Plasma extravasation

Indexed keywords

ACETYLCHOLINE; BRADYKININ; KETOPROFEN LYSINE; LEUKOTRIENE C4; NIMESULIDE; PROSTANOID; THROMBOXANE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHOSPASM; CAPILLARY PERMEABILITY; DOSE RESPONSE; DRUG ACTIVITY; DRUG POTENCY; EXTRAVASATION; GUINEA PIG; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRADYKININ; BRONCHOCONSTRICTION; CAPILLARY PERMEABILITY; CYCLOOXYGENASE INHIBITORS; GUINEA PIGS; KETOPROFEN; LEUKOTRIENE C4; LYSINE; MALE; THROMBOXANE B2; TRACHEA;

EID: 0029953234     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02259613     Document Type: Article

References (28)

1. Hayball PJ, Nation RL, Bochner F. Enantioselective pharmacodynamics of the nonsteroidal antiinflammatory drug keioprofen. Chirality 1993;4:484-7.
2. Veys EM. 20 year's experience with ketoprofen. Scan J Rheumatol 1991;Suppl90:3-44.
3. Regoli D, Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980;32:1-46.
4. Trifillieff A, Da Silva A, Gies JP. Kinins and the respiratory tract diseases. Eur Respir J 1993;6:576-87.
5. Proud D, Kinins. In:Barnes PJ, Rodger IW, Thomson NC, editors Asthma. Basic mechanism and clinical management. London: Academic Press Ltd., 1992:277-85.
6. Proud D, Togias A, Naclerio RM, Crush SA, Norman PS, Lichtenstein LM. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest 1983;72:1678-85.
7. Proud D, Naclerio RM, Gwaltney JMJr, Hendley JO. Kinins are generated in nasal secretions during natural rhinovirus colds. J Infect Dis 1990;161:120-3.
8. Carter Barnett JK, Cruse LW, Proud D. Kinins are generated in nasal secretions during influenza A infections in ferrets. Am Rev Respir Dis 1990;142:162-6.
9. Proud D, Reynolds CJ, LaCapra S, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Nasal provocation with bradykinin induced symptoms of rhinitis and a sore throat. Am Rev Respir Dis 1988;137:613-6.
10. Drazen JM. Cysteinil Leukotrienes. In: Barnes PJ, Rodger IW, Thomson NC, editors. Asthma. Basic mechanism and clinical management. London: Academic Press Ltd., 1992:235-47.
11. 2 generation and effect of aspirin. Prostaglandins 1980;20:547-57.
12. 2 in guinea-pig in vivo. Pharmacol Res Comm 1981;13:633-40.
13. 2 or leukotriene. Br J Pharmacol 1993;110:657-64.
14. Ichinose M, Belvisi MG, Barnes PJ. Bradykinin-induced bronchoconstriction in guinea-pigs in vivo: role of neural mechanism. J Pharmacol Exp Ther 1990;253:594-9.
15. Saria A, Lundberg JM, Skofitsch G, Lemberk F. Vascular protein leakage in various tissues induced by substance P, capsaicin, bradykinin, serotonin, histamine and antigen challenge. Naunyn Schmied Arch Pharmacol 1983;324:212-8.
16. Bellussi L, Passali D. Treatment of upper airways inflammation with nimesulide. Drugs 1993;46 Suppl 1:107-10.
17. Sofia M, Molino A, Mormile M, Stanziola A, Scaricabarozzi I, Carratù L. Nimesulide in the treatment of chronic bronchitis. Drugs 1993;46 Suppl 1:111-4.
18. 2 generation in isolated lungs of the guinea-pig. Br J Pharmacol 1980;68:467-72.
19. Berti F, Rossoni G, Bruschi A, Villa LM, Trento F, Della Bella D, et al. Influence of theophylline on both bronchoconstriction and plasma extravasation induced by acetaldehyde in guinea-pigs. Arzneim Forsch Drug Res 1994;44,3:323-6.
20. Rogers DF, Dijk S, Barnes PJ. Bradykinin-induced plasma exudation in guinea-pigs airways: involvement of platelet activating factor. Br J Pharmacol 1990;101:739-45.
21. Maggi CA, Patacchini R, Santiccioli P, Geppetti P, Cecconi R, Giuliani S, et al. Multiple mechanism in the motor responses of guinea-pig isolated urinary bladder to bradykinin. Br J Pharmacol 1989;98:619-9.
22. MacLean DB, Hayes L. Bradykinin-evoked release of calcitonin gene-related peptide (CGRP) and substance P (SP) from cultured vagal sensory neurons: inhibition by indomethacin. Soc Neurosci Abstr 1990;15:80-2.
23. Fuller RW, Dixon CM, Cuss FM, Barnes PJ. Bradykinin-induced bronchoconstriction in humans: mode of action. Am Rev Respir Dis 1987;135:176-80.
24. Polosa R, Phillips GD, Lai CK, Holgate ST. Contribution of histamine and prostaglandins to bronchoconstriction provoked by inhalation of bradykinin in atopic asthma. Allergy 1990;45:174-82.
25. Churchill L, Pongracic JA, Reynolds CJ, Naclerio RM, Proud D. Pharmacology of nasal provocation with bradykinin: studies of tachyphylaxix, cyclooxygenase inhibition, alpha-adrenergic stimulation, and receptor subtype. Int Arch Allergy Appl Immunol 1991;95:322-31.
26. Baraniuk JN, Silver PB, Kaliner MA, Barnes PJ. Ibuprofen augments bradykinin-induced glycoconjugate secretion by human nasal mucosa in vivo. J Allergy Clin Immunol 1992;89:1032-9.
27. Mira E, Mevio E, Perotti M. Treatment of pharyngitis and pharyngolaringitis. Comparison of phenylprenazone and flurbiprofen (Froben RTM) administered orally and rectally. Clin Trials J 1984;21:100-8.
28. Olive G, Bertin L, Pons G, Lasfargues G, Duhamel JF, Maudelonde C, et al. Randomized, double-blind, multicenter controlled trial of ibuprofen for tonsillitis and pharyngitis in children. Eur J Pharmacol 1990;183:1042-3.